Artizan Bio gets $12mm in Series A funding
Gastrointestinal disease-focused Artizan Biosciences Inc. raised $12mm in its Series A financing to Hatteras Venture Partners, Malin Investments, Johnson & Johnson Innovation – JJDC, Osage University Partners, Elm Street Ventures, and new partner Brii Biosciences.
- Drug Discovery Tools
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.